tirzepatide and blurred vision Macular Degeneration: Current Evidence and Monitoring GLP-1 Medications and Your Vision:

More than three times as many females ages 18 to 25 (orange line) received the drugs than males of the same age (blue line)

During periods of brand-name shortage, compounding pharmacies have produced tirzepatide formulations at doses outside the approved manufacturer pen sizes (2.5, 5, 7.5, 10, 12.5, and 15 mg), and sub-therapeutic protocols such as 1 mg, 2.5 mg held indefinitely, or every-other-week scheduling most commonly come through this channel

More research is needed to fully understand how GLP-1 medications affect pregnancy and pregnancy planning, so using reliable contraception while taking this type of medication is suggested (2)

The gradual nature of GLP-1 weight loss represents an advantage, allowing your body to adapt sustainably rather than experiencing rapid changes

What is the status of stem cell treatment

Patients on levothyroxine should have thyroid function monitored after initiating tirzepatide and following dose increases, as adjustments to levothyroxine dosing may be necessary